Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125379901 | 12537990 | 1 | I | 20160615 | 20160707 | 20160707 | EXP | ADR 23526281-001 | GB-HQ SPECIALTY-GB-2016INT000505 | INTERCHEM | 68.00 | YR | F | Y | 0.00000 | 20160707 | OT | GB | GB |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125379901 | 12537990 | 1 | PS | METHOTREXATE SODIUM. | METHOTREXATE SODIUM | 1 | Unknown | UNK | U | 201749 | |||||||||
| 125379901 | 12537990 | 2 | SS | SULFASALAZINE. | SULFASALAZINE | 1 | UNK | U | 0 | ||||||||||
| 125379901 | 12537990 | 3 | SS | SIMPONI | GOLIMUMAB | 1 | Subcutaneous | UNK | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 125379901 | 12537990 | 1 | Product used for unknown indication |
| 125379901 | 12537990 | 2 | Product used for unknown indication |
| 125379901 | 12537990 | 3 | Product used for unknown indication |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 125379901 | 12537990 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 125379901 | 12537990 | Cough | |
| 125379901 | 12537990 | Initial insomnia | |
| 125379901 | 12537990 | Peripheral swelling | |
| 125379901 | 12537990 | Ureterocele |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| no results found |